The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways

@article{Millan2003TheNM,
  title={The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways},
  author={M. Millan and A. Gobert and F. Lejeune and A. Dekeyne and A. Newman-Tancredi and V. Pasteau and J.‐M. Rivet and D. Cussac},
  journal={Journal of Pharmacology and Experimental Therapeutics},
  year={2003},
  volume={306},
  pages={954 - 964}
}
  • M. Millan, A. Gobert, +5 authors D. Cussac
  • Published 2003
  • Chemistry, Medicine
  • Journal of Pharmacology and Experimental Therapeutics
  • Agomelatine (S20098) displayed pKi values of 6.4 and 6.2 at native (porcine) and cloned, human (h)5-hydroxytryptamine (5-HT)2C receptors, respectively. It also interacted with h5-HT2B receptors (6.6), whereas it showed low affinity at native (rat)/cloned, human 5-HT2A (<5.0/5.3) and 5-HT1A (<5.0/5.2) receptors, and negligible (<5.0) affinity for other 5-HT receptors. In antibody capture/scintillation proximity assays, agomelatine concentration dependently and competitively abolished h5-HT2C… CONTINUE READING
    468 Citations

    Paper Mentions

    S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models
    • 116
    The effect of agomelatine on 5HT2C receptors in humans: a clinically relevant mechanism?
    • 7
    • Highly Influenced
    The melatonergic agonist and clinically active antidepressant, agomelatine, is a neutral antagonist at 5-HT(2C) receptors.
    • 46
    • PDF

    References

    SHOWING 1-10 OF 74 REFERENCES
    5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential.
    • 310
    5-HT2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists.
    • 116
    Melatonin modulates the sensitivity of 5-hydroxytryptamine-2 receptor-mediated sleep—wakefulness regulation in the rat
    • 43
    Serotonin 5-HT2c agonists mimic the effect of light pulses on circadian rhythms
    • 101
    Melatonin agonists modulate 5-HT2A receptor-mediated neurotransmission: behavioral and biochemical studies in the rat.
    • 60
    Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT2C antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study
    • 348
    • Highly Influential